Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel
Alkis Togias(National Institute of Allergy and Infectious Diseases), Joshua A. Boyce(Brigham and Women's Hospital), Hugh A. Sampson(Icahn School of Medicine at Mount Sinai), Kari Keaton(ENT and Allergy), Daniel Rotrosen, Matthew Greenhawt(University of Michigan), David M. Fleischer(Children's Hospital Colorado), James R. Baker(University of Michigan), Maria L. Acebal(Food Allergy Research and Education), Lanny J. Rosenwasser(University of Missouri–Kansas City), Amal Assa’ad(Cincinnati Children's Hospital Medical Center), Michele Habich(Central DuPage Hospital), Jonathan M. Spergel(University of Pennsylvania), Julie Block(Rafael Advanced Defense Systems (Israel)), Robert Sidbury(Seattle Children's Hospital), George J. Fuchs, Glenn T. Furuta(Children's Hospital Colorado), Scott H. Sicherer(Icahn School of Medicine at Mount Sinai), Carol Byrd‐Bredbenner(Rutgers, The State University of New Jersey), Lawrence F. Eichenfield(University of California San Diego), Marshall Plaut(National Institutes of Health), Lynda C. Schneider(Boston Children's Hospital), Antonella Muraro(University of Padua), Lisa A. Beck(University of Rochester Medicine), Stacie M. Jones(Arkansas Children's Hospital), Susan F. Cooper(National Institutes of Health), David R. Stukus(The Ohio State University), Edmond S. Chan(University of British Columbia), Ruchi S. Gupta, Carina Venter(Children's Hospital Colorado)
Cited by 502
Related Papers
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
|Journal of Allergy and Clinical Immunology|2006|2.3k
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k